SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Covance (CVD)
An SI Board Since July 1999
Posts SubjectMarks Bans
10 1 0
Emcee:  pcyhuang Type:  Unmoderated
Introduction Compact
Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with 1998 revenues of $732 million, operations currently in 17 countries, and approximately 7,700 employees worldwide. Covance's purpose is to lead advancements in drug development through science, service, and shaping solutions.

At its current price $20, is it a value-growth investment?

pcyhuang
huangcapital.com
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
10Someone asked me to check this stock. It's so quiet here!Sancon Fan-6/2/2008
9Wake up time... siliconinvestor.com RWRRWReeves-7/12/2000
8 Covance (CVD) was listed with several other market gems as biotechnology, medicblackmerlin-2/20/2000
7 I just bought in at 11. What does everyone think of the news today????? Daniel Levin-11/19/1999
6 Deutsche Banc Alex. Brown initiates coverage of drug contract research organizaPlatter-10/13/1999
5 I just bought some CVD for the long term. If you look at this company compared investmentpaysoff-10/6/1999
4 Covance Inc. (CVD) : PMG upgrades contract research organization from "holPlatter-10/5/1999
3 Contract research organizations (CROs) -- the outsourced drug development subsehoyasaxa-9/9/1999
2 Hi, Boyasaxa: You wrote: "...CROs in general (in particular QTRN) represpcyhuang-9/9/1999
1 thought is was cheap at 20, even cheaper now at 10. despite lowered growth expehoyasaxa-9/8/1999
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News